11th North West Lipid & Atherosclerosis Forum: 18 Sep 2018

What: 11th North West Lipid & Atherosclerosis Forum

When: Tuesday, 18th September 2018

Where: Radisson BLU Hotel, Chicago Avenue, Manchester Airport, Manchester, M90 3RA

Programme

0830 – 0900 Registration & Coffee  
0900 Welcome Dr Handrean Soran
0905 First Session Chairs: Dr Michael France & TBC
0910–0940 Managing hypertension: clinical guidelines and how to individualise treatment? Professor Anthony Heagerty, University of Manchester, UK
0940-1010 A systematic evaluation of glucose lowering therapy and cardiovascular risk: past and present. TBC
1010-1040 Optimizing treatment of Hyperlipidaemia: quantitative evaluation of UK, USA and European guidelines Professor Paul Durrington, University of Manchester, UK
1040-1105 Case presentation

Moderated Panel discussion

Dr Handrean Soran
1105 – 1135 Coffee  and Networking  
1135 Second session          Chairs: Professor Sean Carroll and Dr Basil Iissa
1135-1205 FCS: the disease burden, diagnosis and data from gene therapy. Prof Elisabeth Steinhagen-Thiessen, Berlin, Germany
1205-1335 Recent advances in lipid modification therapy: PCSK9i trials and new therapies for severe hypertriglyceridaemia Dr Handrean Soran, Manchester University Hospital, Manchester, UK
1235-1305 PCSK9, LDL-R and diabetes: from molecular mechanisms to clinical implications. Professor Giuseppe Danilo Norata, Milan, Italy
1305-1315 Panel discussion  
1315 – 1400 Lunch and Networking  
1400 Third session Chairs: Dr Rachelle Donn and Dr Lance Sandle
1400-1430 HDL cholesterol as a therapeutic target: A critical appraisal of previous clinical trials and how can we do better? TBC
 1430-1500 Autoimmunity against HDL/apoA-1: an emergent marker and mediator of cardiovascular risk. Prof Nicolas Vuilleumier, Geneva Faculty of Medicine, Switzerland
1500 – 1515 Coffee  and Networking  
1400 Fourth session Chairs: Dr Dermot Neely, Newcastle, UK & TBC
1510-1540 Lipid lowering nutraceuticals in clinical practice and recent advances Prof Maceij Banach, Warsaw, Poland
1540-1610 Lipoprotein (a) as a cardiovascular risk factor: what HEART UK says? Dr Jaimini  Cegla

Imperial College, London

1420–1440 Coffee and Networking

Feedback/Close

 
1550 END

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s